Facilitating Home Hospice Transitions of Care in Oncology: Evaluation of Clinical Pharmacists’ Interventions, Hospice Program Satisfaction, and Patient Representation Rates

Duffy, Alison; Bemben, Nina M.; Li, Jueli; Trovato, James A.

doi:10.1177/1049909118765944

Cited by 14 publications

(25 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Studies conducted globally have confirmed the benefit of the integration of the OPT as part the MHT within a variety of settings in improving overall patient care. 22–52…”

Section: Contributions To Patient Carementioning

confidence: 99%

International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care

Holle

Bilse

Alabelewe

et al. 2021

J Oncol Pharm Pract

View full text Add to dashboard Cite

The Oncology Pharmacy Team (OPT), consisting of specialty-trained pharmacists and/or pharmacy technicians, is an integral component of the multidisciplinary healthcare team (MHT) involved with all aspects of cancer patient care. The OPT fosters quality patient care, safety, and local regulatory compliance. The International Society of Oncology Pharmacy Practitioners (ISOPP) developed this position statement to provide guidance on five key areas: 1) oncology pharmacy practice as a pharmacy specialty; 2) contributions to patient care; 3) oncology pharmacy practice management; 4) education and training; and 5) contributions to oncology research and quality initiatives to involve the OPT. This position statement advocates that: 1) the OPT be fully incorporated into the MHT to optimize patient care; 2) educational and healthcare institutions develop programs to continually educate OPT members; and 3) regulatory authorities develop certification programs to recognize the unique contributions of the OPT in cancer patient care.

show abstract

“…Studies conducted globally have confirmed the benefit of the integration of the OPT as part the MHT within a variety of settings in improving overall patient care. 22–52…”

Section: Contributions To Patient Carementioning

confidence: 99%

International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care

Holle

Bilse

Alabelewe

et al. 2021

J Oncol Pharm Pract

View full text Add to dashboard Cite

show abstract

“…22 The study designs were varied (case report, descriptive and observational studies, and randomized controlled trial), although three studies did not report their study designs. 17,20,23 The majority of the studies was conducted in ambulatory/clinics (n = 10), 15–19,21–24,28 followed by inpatient units (n = 2), 25,26 community pharmacy (n = 1), 27 and home care programme (n = 1). 20 The number of patients included in the studies was very variable, ranging from 1 to 215 patients (1 to 162 assessed by pharmacists).…”

Section: Resultsmentioning

confidence: 99%

“…Table 2 shows the activities and-or services provided by clinical pharmacists as well as the duration, frequency and recurrence of pharmacist performance, outcomes measured and method to classify or measure these outcomes, and summary of the results of the studies included in this scoping review. The main activities and-or services provided by pharmacists were the following: conducting medication review (n = 12), 15–19,21–23,25–28 taking medication histories and-or conducting medication reconciliation (n = 6), 17–19,21,23,25 educating and counselling patients, caregivers, and families on medication issues (n = 12), 15–21,23,24,26–28 conducting disease management (focused on pain) (n = 1), 24 and even administrative roles (n = 2), such as medication supply and communication with community resources to ensure that efficient distribution of medication to the patient was not compromised. 19,25 Nine studies clearly described the pharmacist's follow-up with patients (not always with all patients); 15–17,19–21,24,27,28 among them, five studies clearly reported the time between one assessment and another.…”

Section: Resultsmentioning

confidence: 99%

Role of clinical pharmacist in the palliative care of adults and elderly patients with cancer: A scoping review

Franco

Souza

Lima

et al. 2022

J Oncol Pharm Pract

View full text Add to dashboard Cite

Objective: We conducted this scoping review to map and summarize scientific evidence on the role of clinical pharmacists in the palliative care of adults and elderly patients with cancer. Data Sources: A literature search was performed in MEDLINE, PubMed Central, Embase, Web of Science, Scopus, and BVS/BIREME for studies published until November 22nd, 2020. Studies that reported work experiences adopted by clinical pharmacists in the palliative care of adults and elderly patients with cancer were included. Two independent authors performed study selection and data extraction. Any disagreements were resolved by discussion with the third and fourth authors. The pharmacist interventions identified in the included studies were described based on key domains in the DEPICT v.2. Data Summary: A total of 586 records were identified, of which 14 studies fully met the eligibility criteria. Most of them were conducted in the United States of America (n = 5) and Canada (n = 5) and described the workplace of the pharmacist in clinic/ambulatory (n = 10). Clinical pharmacists performed several activities and provided services, highlighting medication review (n = 12), patient and caregivers education (n = 12), medication histories and-or medication reconciliation (n = 6). The pharmacist interventions were mostly conducted for patients/caregivers (n = 13), by one-on-one contact (n = 14), and by face-to-face (n = 13). Pharmacists were responsible mainly for change or suggestion for change in therapy (n = 12) and patient counselling (n = 12). Pharmacist interventions were well accepted by the clinical team. Overall, studies showed that pharmacists, within an interdisciplinary team, had significant impacts on measured outcomes. Conclusions: In recent years, there have been advances in the role of the pharmacist in palliative care of patients with cancer and there are great opportunities in this field. They play an important role in managing cancer pain and other symptoms, as well as resolving drug related problems. We encourage more research to be carried out to strengthen this field and to benefit patients with advanced cancer with higher quality of life.

show abstract

“…Un pharmacien désirant absolument voir un patient avant son congé devait continuer d'utiliser d'autres approches pour le faire, comme un avis verbal à l'infirmière et au médecin traitant. Plusieurs études mettent en évidence l'utilité d'une liste de contrôle multidisciplinaire à dresser avant le congé d'un patient adulte [13][14][15][16][17][18] . Voirol et collab.…”

Section: Formulaire De Congé Standardiséunclassified

Soins plus — mise en place d’une intervention à trois volets visant à accroître la visibilité et la disponibilité du pharmacien dans un hôpital pédiatrique : une étude randomisée contrôlée

Mosora

Guèvremont

Vézina

et al. 2021

CJHP

View full text Add to dashboard Cite

RÉSUMÉ Contexte : Le rôle du pharmacien au sein de l’équipe multidisciplinaire est souvent méconnu. Diverses interventions peuvent être mises en place pour promouvoir le rôle du pharmacien en milieu hospitalier auprès des familles, des patients et des autres professionnels de la santé. Peu d’études décrivent la faisabilité et évaluent l’impact de ces interventions, particulièrement en pédiatrie. Objectifs : Décrire l’implantation d’une intervention à trois volets visant à accroître la visibilité du pharmacien et de son rôle dans l’équipe traitante, pour permettre d’optimiser les soins pharmaceutiques des patients hospitalisés dans les unités de pédiatrie générale du CHU Sainte-Justine, à Montréal (Québec). Comparer la perception et la satisfaction des parents de patients hospitalisés et des soignants recevant soit des soins pharmaceutiques usuels, ou soit des soins pharmaceutiques intégrant l’intervention. Méthode : Étude expérimentale randomisée contrôlée à simple aveugle portant sur des patients admis dans les unités de pédiatrie générale entre le 5 mars et le 8 août 2019. Outre des soins usuels, l’intervention comporte la remise d’une brochure d’information sur les services et soins pharmaceutiques, l’accès à une ligne téléphonique permettant aux familles et aux patients de prendre contact avec un résident en pharmacie pendant leur séjour à l’hôpital et jusqu’à un mois après le congé et le remplissage par le pharmacien responsable du patient d’un formulaire de congé standardisé. Un sondage de perception et de satisfaction a aussi été réalisé auprès des participants et des professionnels de la santé concernés. Résultats : Six cent quarante et un (641) participants ont été inclus dans l’étude, 321 dans le groupe intervention et 320 dans le groupe témoin. La brochure a été remise à tous les parents du groupe intervention. Douze appels téléphoniques ont été faits au moyen d’une ligne téléphonique spéciale. Le formulaire de congé standardisé de 46,7 % (150/321) des participants du groupe intervention a été rempli. Une majorité des parents et des patients ayant répondu au sondage (81,2 %, 298/367) se disent satisfaits des services et des soins pharmaceutiques reçus dans les deux groupes. Une proportion de 83,9 % des participants du groupe intervention se disent satisfaits des soins et services pharmaceutiques reçus comparativement à 78,5 % du groupe témoin (p = 0,18). De plus, 60,3 % (111/184) des participants du groupe intervention disent que l’information transmise pendant l’hospitalisation concernant les médicaments leur a apporté de nouvelles connaissances, contre 48,1 % (87/181) des participants du groupe témoin (p = 0,019). Les résultats du sondage montrent que les soignants sont en accord avec l’intervention. Conclusion : Les trois volets de l’intervention ont été implantés dans les unités de pédiatrie sur une période de cinq mois. Cette intervention est perçue comme étant positive par les parents et les soignants concernés et les répondants ont été majoritairement satisfaits des services et des soins pharmaceutiques offerts. ABSTRACT Background: The pharmacist’s role within the multidisciplinary team is often poorly understood. Various interventions can be put into place to promote the role of the pharmacist in the hospital setting with families, patients, and other health care professionals. Few studies have described the feasibility and assessed the impact of such interventions, particularly in pediatrics. Objectives: To describe the implementation of a 3-part intervention aimed at increasing the visibility of pharmacists and their role on the treatment team, with the goal of optimizing the pharmaceutical care of hospitalized patients in the general pediatric units of CHU Sainte-Justine, in Montréal, Quebec, and to compare the perceptions and satisfaction of patients’ parents and of health care professionals with exposure to either usual pharmaceutical care or to pharmaceutical care incorporating the intervention. Methods: This single-blind, randomized, controlled experimental study involved patients admitted to general pediatric units between March 5 and August 8, 2019. In addition to usual care, the intervention included delivery of an information brochure about pharmaceutical services and care, access to a telephone line (which allowed families and patients to contact a pharmacy resident during their stay in hospital and up to 1 month after discharge), and completion of a standardized discharge form by the pharmacist responsible for the patient. The participants and health professionals concerned were surveyed to determine their perceptions and level of satisfaction. Results: A total of 641 participants were included in the study, 321 in the intervention group and 320 in the control group. The brochure was given to all parents in the intervention group. Twelve phone calls were made through the dedicated telephone line. The standardized discharge form was completed for 46.7% (150/321) of the participants in the intervention group. Most of the parents and patients who responded to the survey, in either group (81.2%, 298/367), reported satisfaction with the pharmaceutical services and care received. Of participants in the intervention group, 83.9% were satisfied with the pharmaceutical care and services received, compared with 78.5% of those in the control group (p = 0.18). In addition, 60.3% (111/184) of participants in the intervention group said that the information about medications that was provided during the hospital stay gave them new knowledge, compared with 48.1% (87/181) of those in the control group (p = 0.019). The results of the survey showed that care providers were in agreement with the intervention. Conclusions: The 3 components of the intervention were implemented in the pediatric units over a period of 5 months. The intervention was perceived as positive by the parents and care providers concerned, and the respondents were mostly satisfied with the services and pharmaceutical care offered.

show abstract

Facilitating Home Hospice Transitions of Care in Oncology: Evaluation of Clinical Pharmacists’ Interventions, Hospice Program Satisfaction, and Patient Representation Rates

Cited by 14 publications

References 8 publications

International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care

International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care

Role of clinical pharmacist in the palliative care of adults and elderly patients with cancer: A scoping review

Soins plus — mise en place d’une intervention à trois volets visant à accroître la visibilité et la disponibilité du pharmacien dans un hôpital pédiatrique : une étude randomisée contrôlée

Contact Info

Product

Resources

About